Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Dimebon

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Parkinson’s Disease Dementia

early alzheimer's3 - synaptic loss1 - hd patients1 - semantic dementia1 - terminal cognitive failure1 - abeta1 - beta-blocker drugs1 - brain injury1 - mini-strokes2 - aortic valve stenosis2 - alzheimers association1 - wernicke-korsakoff syndrome15 - risk of parkinson's1 - sodium benzoate1 - amnesia1 - apolipoprotein e2 - pneumonia1 - functional activation studies1 - alzheimer's markers1 - regular caffeine consumption1 - pick's disease2 - early detection of dementia1 - chuanhai cao1 - ipscs1 - cotard's syndrome1 - huntington's chorea1 - vascular health1 - ad risk factors1 - chronic sleep deprivation1 - late-onset alzheimers disease1 -